泓博医药
(301230)
| 流通市值：49.39亿 | | | 总市值：54.89亿 |
| 流通股本：1.26亿 | | | 总股本：1.40亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 73,019,064.28 | 59,111,113.54 | 55,315,891.49 | 101,235,423.23 |
| 交易性金融资产 | 215,145,853.36 | 248,976,051.37 | 247,157,476.03 | 245,338,900.68 |
| 应收票据及应收账款 | 139,552,808.04 | 148,431,334.87 | 138,425,951.48 | 154,327,357.48 |
| 其中：应收票据 | 5,373,958.47 | 1,417,352.94 | 1,916,102.5 | 10,883,435.76 |
| 应收账款 | 134,178,849.57 | 147,013,981.93 | 136,509,848.98 | 143,443,921.72 |
| 应收款项融资 | 10,321,710.98 | 2,920,841.36 | 1,027,858.55 | 3,469,004 |
| 预付款项 | 4,145,649.07 | 5,040,532.72 | 4,426,100.94 | 4,077,027.68 |
| 其他应收款合计 | 4,723,342.15 | 4,651,686.21 | 4,753,988.86 | 4,646,566.76 |
| 存货 | 90,870,031.28 | 74,046,988.08 | 71,603,894.47 | 66,996,326.51 |
| 合同资产 | - | 0 | - | - |
| 其他流动资产 | 40,355,046.36 | 38,917,357.52 | 40,166,523.68 | 38,843,665.58 |
| 流动资产合计 | 578,133,505.52 | 582,095,905.67 | 562,877,685.5 | 618,934,271.92 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 72,464,025 | 33,170,832 | 33,187,160 | 19,824,848 |
| 固定资产 | 193,651,683.31 | 194,548,507.86 | 194,575,350.73 | 194,381,898.18 |
| 在建工程 | 7,406,627.82 | 7,332,859.34 | 6,588,958.05 | 2,968,348.26 |
| 使用权资产 | 130,769,792.55 | 136,496,845.05 | 142,223,897.5 | 147,950,950 |
| 无形资产 | 8,500,204.37 | 8,618,862.64 | 8,533,425.25 | 8,570,710.72 |
| 长期待摊费用 | 274,742,379.21 | 283,075,533.83 | 290,239,453.9 | 299,345,594.13 |
| 递延所得税资产 | 48,527,266.48 | 47,195,551.56 | 42,673,610.22 | 39,625,195.65 |
| 其他非流动资产 | 1,647,901.4 | 21,564,277.84 | 24,644,584.21 | 24,984,113.07 |
| 非流动资产合计 | 737,709,880.14 | 732,003,270.12 | 742,666,439.86 | 737,651,658.01 |
| 资产总计 | 1,315,843,385.66 | 1,314,099,175.79 | 1,305,544,125.36 | 1,356,585,929.93 |
| 流动负债: | | | | |
| 短期借款 | 10,010,083.34 | 10,010,083.34 | 18,020,750.24 | 20,669,797.25 |
| 应付票据及应付账款 | 65,877,249.72 | 62,563,735.12 | 47,150,618.9 | 60,826,839.62 |
| 应付账款 | 65,877,249.72 | 62,563,735.12 | 47,150,618.9 | 60,826,839.62 |
| 预收款项 | 301.14 | 1,955,750.6 | 2.36 | - |
| 合同负债 | 5,761,018.59 | 6,191,549.35 | 7,551,963.74 | 3,548,918.92 |
| 应付职工薪酬 | 34,193,293.97 | 43,738,603.38 | 31,391,865.07 | 25,691,842.77 |
| 应交税费 | 2,724,162.89 | 2,298,152.01 | 3,299,419.51 | 2,790,742.82 |
| 其他应付款合计 | 5,793,372.4 | 17,927,118.05 | 6,121,968.96 | 3,615,577.1 |
| 一年内到期的非流动负债 | 23,702,238.34 | 25,994,525.19 | 22,638,775.27 | 22,116,715.29 |
| 其他流动负债 | 5,692,795.6 | 1,532,528.63 | 1,832,393.02 | 10,363,452.03 |
| 流动负债合计 | 153,754,515.99 | 172,212,045.67 | 138,007,757.07 | 149,623,885.8 |
| 非流动负债: | | | | |
| 租赁负债 | 125,642,741.88 | 129,304,380.46 | 134,333,677.29 | 140,682,630.96 |
| 预计负债 | 495,104.6 | 3,978,717.87 | 2,865,037.49 | 2,191,413.87 |
| 递延收益 | 218,511.37 | 218,511.37 | 219,911.37 | 221,591.37 |
| 递延所得税负债 | 5,780,948.17 | 4,155,412.6 | 3,934,796.97 | 3,702,799.73 |
| 非流动负债合计 | 132,137,306.02 | 137,657,022.3 | 141,353,423.12 | 146,798,435.93 |
| 负债合计 | 285,891,822.01 | 309,869,067.97 | 279,361,180.19 | 296,422,321.73 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 139,586,605 | 139,586,605 | 139,586,605 | 139,586,605 |
| 资本公积 | 774,983,792.4 | 772,927,119.67 | 771,013,817.28 | 769,627,198.32 |
| 减:库存股 | 53,080,912.43 | 53,080,912.43 | 53,080,912.43 | 53,080,912.43 |
| 其他综合收益 | -158,438.27 | -43,971.87 | -14,512.92 | -47,411.59 |
| 盈余公积 | 34,999,933.96 | 34,999,933.96 | 29,841,348.57 | 29,841,348.57 |
| 未分配利润 | 133,620,582.99 | 109,841,333.49 | 138,836,599.67 | 174,236,780.33 |
| 归属于母公司股东权益合计 | 1,029,951,563.65 | 1,004,230,107.82 | 1,026,182,945.17 | 1,060,163,608.2 |
| 股东权益合计 | 1,029,951,563.65 | 1,004,230,107.82 | 1,026,182,945.17 | 1,060,163,608.2 |
| 负债和股东权益合计 | 1,315,843,385.66 | 1,314,099,175.79 | 1,305,544,125.36 | 1,356,585,929.93 |
| 公告日期 | 2026-04-29 | 2026-04-29 | 2025-10-30 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |